litlas
Log inCreate account

Walter Ling

Active 1970–2021

85
Papers
18,455
Citations
79
h-index
85
i10-index

Citations

Citations per year for Walter Ling1973: 1 citations1976: 2 citations1978: 4 citations1980: 2 citations1981: 1 citations1982: 1 citations1983: 1 citations1987: 3 citations1988: 2 citations1989: 1 citations1990: 1 citations1991: 2 citations1992: 1 citations1993: 2 citations1994: 5 citations1995: 4 citations1996: 6 citations1997: 7 citations1998: 11 citations1999: 19 citations2000: 50 citations2001: 30 citations2002: 83 citations2003: 84 citations2004: 129 citations2005: 187 citations2006: 184 citations2007: 154 citations2008: 168 citations2009: 150 citations2010: 165 citations2011: 121 citations2012: 136 citations2013: 112 citations2014: 123 citations2015: 148 citations2016: 129 citations2017: 129 citations2018: 116 citations2019: 482 citations2020: 518 citations2021: 445 citations2022: 326 citations2023: 162 citations2024: 310 citations2025: 78 citations2026: 6 citations1974–1975: no citations, so these years are not shown1977: no citations, so this year is not shown1979: no citations, so this year is not shown1984–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,350 citing papers, 54.8% of this breakdownCanada: 228 citing papers, 5.3% of this breakdownAustralia: 222 citing papers, 5.2% of this breakdownUnited Kingdom: 220 citing papers, 5.1% of this breakdownChina: 95 citing papers, 2.2% of this breakdownItaly: 88 citing papers, 2.1% of this breakdownGermany: 81 citing papers, 1.9% of this breakdownFrance: 75 citing papers, 1.7% of this breakdownSpain: 61 citing papers, 1.4% of this breakdownSwitzerland: 51 citing papers, 1.2% of this breakdownNetherlands: 47 citing papers, 1.1% of this breakdownIran: 42 citing papers, 1% of this breakdown
0%54.8%Other 17%

Institutions

Fields

  • Medicine63.8%
  • Neuroscience19.8%
  • Psychology6.8%
  • Pharmacology, Toxicology and Pharmaceutics2.7%
  • Biochemistry, Genetics and Molecular Biology2.2%
  • Health Professions1.4%
  • Other3.3%

Topics

  • Substance Abuse Treatment and Outcomes13.7%
  • Opioid Use Disorder Treatment13.6%
  • Neurotransmitter Receptor Influence on Behavior8.2%
  • HIV, Drug Use, Sexual Risk5.7%
  • Forensic Toxicology and Drug Analysis3.7%
  • Pain Management and Opioid Use3.3%
  • Other51.8%

Coauthors

All papers

Open in search
  1. DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale

    Authors: Deborah S. Hasin, Charles P. O’Brien, Marc Auriacombe, Guilherme Borges, Kathleen K. Bucholz, Alan J. Budney, Wilson M. Compton, Thomas J. Crowley, Walter Ling, Nancy M. Petry, Marc A. Schuckit, Bridget F. Grant - American Journal of Psychiatry 2013 cited by 1,603

  2. The Clinical Opiate Withdrawal Scale (COWS)

    Authors: Donald R. Wesson, Walter Ling - Journal of Psychoactive Drugs 2003 cited by 1,101

  3. Validation of the alcohol, smoking and substance involvement screening test (ASSIST)

    Authors: Rachel Humeniuk, Robert Ali, Thomas F. Babor, Michael Farrell, Maria Lúcia Oliveira de Souza Formigoni, Jaroon Jittiwutikarn, Roseli Boerngen de Lacerda, Walter Ling, John Marsden, Maristela Monteiro, Sekai Nhiwatiwa, Hemraj Pal, Vladimir Poznyak, Sara L. Simon - Addiction 2008 cited by 1,136

  4. Bupropion and Naltrexone in Methamphetamine Use Disorder

    Authors: Madhukar H. Trivedi, Robrina Walker, Walter Ling, Adriane M. dela Cruz, Gaurav Sharma, Thomas Carmody, Udi E. Ghitza, Aimee Wahle, Mora Kim, Kathy Shores‐Wilson, Steven Sparenborg, Phillip O. Coffin, Joy M. Schmitz, Katharina Wiest, Gavin Bart, Susan C. Sonne, Sidarth Wakhlu, A. John Rush, Edward V. Nunes, Steven Shoptaw - New England Journal of Medicine 2021 cited by 263

  5. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Barbara R. Haight, Susan M. Learned, Céline M. Laffont, Paul J. Fudala, Yue Zhao, Amanda Garofalo, Mark K. Greenwald, Vijay R. Nadipelli, Walter Ling, Christian Heidbreder, James Andersen, Genie L. Bailey, Scott Robert Bartley, Michael J. Biunno, Brent Boyett, Jesse M. Carr, Eduardo Cifuentes, Sandra Daniela Duarte-Sckell, Otto R. Dueno, Boyde Harrison, David Hassman, Kent Hoffman, Valentin Isacesu, Saleem Ishaque, Rishi Kakar, Kyle M. Kampman, Richard D. Knapp, George Konis, Jelena Kunovac, Joseph A. Kwentus, Lawrence S. Levinson, Shishuka Malhotra, Vishaal Mehra, Ricky Mofsen, Marvin L. Peyton, Gita G. Pujari, Rakesh Ranjan, Daniel Rutrick, Gregory Seal, Scott Daniel Segal, Rajinder Shiwach, Haydn M. Thomas, Peter Paul Ventre, Amit K. Vijapura, David P. Walling, Katharina Wiest - The Lancet 2019 cited by 284

  6. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial

    Authors: Yih‐Ing Hser, Andrew J. Saxon, David Huang, Al Hasson, Christie Thomas, Maureen Hillhouse, Petra Jacobs, Cheryl Teruya, Paul McLaughlin, Katharina Wiest, Allan Cohen, Walter Ling - Addiction 2013 cited by 457

  7. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

    Authors: Evgeny Krupitsky, Edward V. Nunes, Walter Ling, Ari Illeperuma, David R. Gastfriend, Bernard L. Silverman - The Lancet 2011 cited by 554

  8. Long-Term Course of Opioid Addiction

    Authors: Yih‐Ing Hser, Elizabeth Evans, Christine E. Grella, Walter Ling, Douglas Anglin - Harvard Review of Psychiatry 2015 cited by 296

  9. Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial

    Authors: Yih‐Ing Hser, Elizabeth Evans, David Huang, Robert A. Weiss, Andrew J. Saxon, Kathleen M. Carroll, George Woody, David Liu, Paul Wakim, Abigail G. Matthews, Mary A. Hatch‐Maillette, Eve Jelstrom, Katharina Wiest, Paul McLaughlin, Walter Ling - Addiction 2015 cited by 216

  10. Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone

    Authors: Paul J. Fudala, T. Peter Bridge, Susan Herbert, William O. Williford, C. Nora Chiang, Karen Jones, Joseph F. Collins, Dennis W. Raisch, Paul Casadonte, R. Jeffrey Goldsmith, Walter Ling, Usha Malkerneker, Laura F. McNicholas, John A. Renner, Susan M. Stine, Donald J. Tusel - New England Journal of Medicine 2003 cited by 583

  11. Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial

    Authors: Sudie E. Back, Rebecca Payne, Amy H. Wahlquist, Rickey E. Carter, Zachary Stroud, Louise Haynes, Maureen Hillhouse, Kathleen T. Brady, Walter Ling - The American Journal of Drug and Alcohol Abuse 2011 cited by 281

  12. Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine

    Authors: Paul M. Thompson, Kiralee M. Hayashi, Sara L. Simon, Jennifer A. Geaga, Michael Hong, Yihong Sui, Jessica Y. Lee, Arthur W. Toga, Walter Ling, Edythe D. London - Journal of Neuroscience 2004 cited by 767

  13. Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term study

    Authors: Walter Ling, Vijay R. Nadipelli, Caitlyn T. Solem, Naoko Ronquest, Yu‐Chen Yeh, Susan M. Learned, Vishaal Mehra, Christian Heidbreder - Journal of Substance Abuse Treatment 2019 cited by 57

  14. Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study

    Authors: Walter Ling, Vijay R. Nadipelli, Arnie Aldridge, Naoko Ronquest, Caitlyn T. Solem, Howard D. Chilcoat, Victoria A. Albright, Courtney Johnson, Susan M. Learned, Vishaal Mehra, Christian Heidbreder - Journal of Addiction Medicine 2020 cited by 53

  15. Mood Disturbances and Regional Cerebral Metabolic Abnormalities inRecently Abstinent Methamphetamine Abusers

    Authors: Edythe D. London, Sara L. Simon, Steven M. Berman, M. Mandelkern, Aaron M. Lichtman, Jennifer E. Bramen, Ann K. Shinn, Karen Miotto, Jennifer E. Learn, Yun Dong, John A. Matochik, Varughese Kurian, Thomas F. Newton, Roger P. Woods, Richard A. Rawson, Walter Ling - Archives of General Psychiatry 2004 cited by 383

  16. HIV Risk Reduction With Buprenorphine–Naloxone or Methadone

    Authors: George Woody, Douglas Bruce, P. Todd Korthuis, Sumedha Chhatre, Sabrina Poole, Maureen Hillhouse, Petra Jacobs, James L. Sorensen, Andrew J. Saxon, David S. Metzger, Walter Ling - JAIDS Journal of Acquired Immune Deficiency Syndromes 2014 cited by 109

  17. Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation

    Authors: Walter Ling, Steven Shoptaw, David Goodman‐Meza - Substance Abuse and Rehabilitation 2019 cited by 52

  18. Bupropion for the Treatment of Methamphetamine Dependence

    Authors: Ahmed Elkashef, Richard A. Rawson, A. Anderson, Shou-Hua Li, Tyson H. Holmes, Edwina Smith, Nora Chiang, Roberta Kahn, Frank J. Vocci, Walter Ling, Valerie Pearce, Michael McCann, Jan Campbell, Charles W. Gorodetzky, William Haning, Barry Carlton, Joseph Mawhinney, Dennis Weis - Neuropsychopharmacology 2007 cited by 231

  19. Prescription opioid abuse, pain and addiction: Clinical issues and implications

    Authors: Walter Ling, Larissa J. Mooney, Maureen Hillhouse - Drug and Alcohol Review 2011 cited by 179

  20. Injectable extended‐release naltrexone (XR‐NTX) for opioid dependence: long‐term safety and effectiveness

    Authors: Evgeny Krupitsky, Edward V. Nunes, Walter Ling, David R. Gastfriend, Aslı Memişoğlu, Bernard L. Silverman - Addiction 2013 cited by 120

  21. Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder

    Authors: Walter Ling, Linda Chang, Maureen Hillhouse, Alfonso Ang, Joan M. Striebel, Jessica N. Jenkins, J. Cortes Hernandez, Mary Olaer, Larissa J. Mooney, Susan Reed, Erin Fukaya, Shannon Kogachi, Daniel Alicata, Nataliya Holmes, Asher E. Esagoff - Addiction 2014 cited by 80

  22. Patient-centered Outcomes in Participants of a Buprenorphine Monthly Depot (BUP-XR) Double-blind, Placebo-controlled, Multicenter, Phase 3 Study

    Authors: Walter Ling, Vijay R. Nadipelli, Caitlyn T. Solem, Naoko Ronquest, Yu‐Chen Yeh, Susan M. Learned, Vishaal Mehra, Christian Heidbreder - Journal of Addiction Medicine 2019 cited by 45

  23. Hyperalgesic responses in methadone maintenance patients

    Authors: Mark Doverty, Jason M. White, Andrew A. Somogyi, Felix Bochner, Robert Ali, Walter Ling - Pain 2001 cited by 303

  24. Cognitive Performance of Current Methamphetamine and Cocaine Abusers

    Authors: Sara L. Simon, Catherine P. Domier, Tiffanie Sim, Kimberly Richardson, Richard A. Rawson, Walter Ling - Journal of Addictive Diseases 2001 cited by 228